Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.
about
Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorshipMicroRNA expression profiling in male and female familial breast cancer.The landscape of candidate driver genes differs between male and female breast cancer.Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study.Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysisMale breast carcinoma: increased awareness needed.Obesity and male breast cancer: provocative parallels?Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplificationGene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker.An international comparison of male and female breast cancer incidence ratesTMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer.Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancerHMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes.The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer.Somatic alterations of targetable oncogenes are frequently observed in BRCA1/2 mutation negative male breast cancers.PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer.Aromatase inhibitors for metastatic male breast cancer: molecular, endocrine, and clinical considerations.The cancer genetics and pathology of male breast cancer.Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.Genome methylation patterns in male breast cancer - Identification of an epitype with hypermethylation of polycomb target genes.Analysis of the ATR-Chk1 and ATM-Chk2 pathways in male breast cancer revealed the prognostic significance of ATR expression.Do columnar cell lesions exist in the male breast?Molecular subtyping of male breast cancer by immunohistochemistry.A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences.Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes.Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.High proliferation is associated with inferior outcome in male breast cancer patients.Tracing differences between male and female breast cancer: both diseases own a different biology.Antiandrogen therapy in metastatic male breast cancer: results from an updated analysis in an expanded case series.Fibrotic focus and hypoxia in male breast cancer.Similarities and differences in the characteristics and primary treatment of breast cancer in men and women - a population based study (Sweden).The 21-Gene Recurrence Score in Male Breast Cancer.Gene-specific methylation profiles in BRCA-mutation positive and BRCA-mutation negative male breast cancers.Survival Comparisons Between Early Male and Female Breast Cancer Patients.
P2860
Q27025244-A29D80FD-A949-4CBF-A8C9-7BE1F24C0FFBQ34687031-6A0B4E9D-F432-4FBD-BECF-29A393044249Q35032523-84940813-57CB-4C44-BC56-74E64DC69E75Q35367903-6FB8855F-BCB8-4C87-AECE-83686E411F74Q35633574-A8C2E11E-5E3C-465B-B49D-C82537073951Q35683518-E9652C82-00CE-4722-954C-B27612BD8712Q35687528-055E0D30-A9FD-463F-97D3-77A89CDDD277Q36147178-25EC0BFD-5802-48B7-BF1E-A861F807CE3CQ36393217-B05F2B4A-70B4-4BB6-992F-F71A15C7DA3BQ36557024-80D47F0C-3DBC-48A7-BD9B-9488892BC7DDQ36689124-DDF60060-CFA3-43BD-AAC1-8881346B3ED8Q37151073-4E07C6AE-B4AA-4385-B58F-F5A74F8198E3Q37319005-949ECBAB-4190-495E-8DB5-AB7B0CD361EBQ37536519-91A3990F-C153-499F-8D64-08BB9F1F5A3CQ37687527-D83F2553-7F48-4559-8923-1E19B0707798Q37690197-84C79D47-C975-4E1F-998B-02B4DEB1CD7EQ38239410-8ADBAD9B-1D05-499B-A3FA-EF1FBBACB105Q38696800-0D699B95-509B-4621-B5DD-8D6818FF8A6AQ40420136-B84BB2F1-416C-46C8-9E87-6D524E4F4A12Q41136382-2C78A3DE-5B89-4E43-8C2E-3E426B790105Q41388351-ECCDFC50-0217-4275-A3F9-B8E28231E2EEQ42449757-BB068FEF-E024-49CE-8300-CD9859A70153Q42496958-E5991629-81FA-4F70-8CC0-A7D54CAA9C06Q42497579-DB624483-981D-4095-8835-4B1C296D2057Q42511496-30001DFA-7B19-483D-A17D-354568A5D787Q42511904-003777AD-6CD7-468F-BEEE-FD4E603AB4C8Q42516409-EA12E2A9-387D-4900-981D-42B5F991515EQ44595171-99FFAEC9-1B2A-46DC-8CF5-A5814D831474Q46532481-860C8069-69ED-4ACE-803F-A23A8B0BCC6AQ50920420-9145B9E3-021B-47EA-87E1-A76EE040EAD5Q51112229-1D5D4AF1-F833-4744-9D11-150AA7DA238AQ51333044-BCDCC8E5-0F26-4702-BBF1-8DC69947FD27Q51427569-354ABF87-3239-40E3-B4CE-98E1A6FC792AQ52665411-B3062C1F-6957-4359-B65D-FB40E738CFF3Q55030444-2FDFD35A-6931-41E2-ABDD-E6F20CA247A0Q55473188-E9AB8E5C-F6E2-4492-BFF1-799389209003
P2860
Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Gene expression analysis revea ...... female and male breast cancer.
@en
Gene expression analysis revea ...... female and male breast cancer.
@nl
type
label
Gene expression analysis revea ...... female and male breast cancer.
@en
Gene expression analysis revea ...... female and male breast cancer.
@nl
prefLabel
Gene expression analysis revea ...... female and male breast cancer.
@en
Gene expression analysis revea ...... female and male breast cancer.
@nl
P2860
P50
P1476
Gene expression analysis revea ...... female and male breast cancer
@en
P2093
Silvia Veneroni
P2860
P2888
P304
P356
10.1007/S10549-010-1015-8
P407
P50
P577
2010-07-13T00:00:00Z